241 related articles for article (PubMed ID: 28585071)
1. Impact of non-transferrin-bound iron (NTBI) in comparison to serum ferritin on outcome after allogeneic stem cell transplantation (ASCT).
Hilken A; Langebrake C; Wolschke C; Kersten JF; Rohde H; Nielsen P; Kröger N
Ann Hematol; 2017 Aug; 96(8):1379-1388. PubMed ID: 28585071
[TBL] [Abstract][Full Text] [Related]
2. Iron overload in patients receiving allogeneic hematopoietic stem cell transplantation: quantification of iron burden by a superconducting quantum interference device (SQUID) and therapeutic effectiveness of phlebotomy.
Busca A; Falda M; Manzini P; D'Antico S; Valfrè A; Locatelli F; Calabrese R; Chiappella A; D'Ardia S; Longo F; Piga A
Biol Blood Marrow Transplant; 2010 Jan; 16(1):115-22. PubMed ID: 19766730
[TBL] [Abstract][Full Text] [Related]
3. Hyperferritinemia after adult allogeneic hematopoietic cell transplantation: quantification of iron burden by determining non-transferrin-bound iron.
Goto T; Ikuta K; Inamoto Y; Kamoshita S; Yokohata E; Koyama D; Onodera K; Seto A; Watanabe K; Imahashi N; Tsukamoto S; Ozawa Y; Sasaki K; Ito M; Kohgo Y; Miyamura K
Int J Hematol; 2013 Jan; 97(1):125-34. PubMed ID: 23264147
[TBL] [Abstract][Full Text] [Related]
4. Measurement of liver iron concentration by superconducting quantum interference device biomagnetic liver susceptometry validates serum ferritin as prognostic parameter for allogeneic stem cell transplantation.
Jacobi N; Herich L
Eur J Haematol; 2016 Oct; 97(4):336-41. PubMed ID: 26800433
[TBL] [Abstract][Full Text] [Related]
5. Pro-oxidative/antioxidative imbalance: a key indicator of adverse outcome in hematopoietic stem cell transplantation.
Yegin ZA; Paşaoğlu H; Aki SZ; Özkurt ZN; Demirtaş C; Yağci M; Acar K; Sucak GT
Int J Lab Hematol; 2011 Aug; 33(4):414-23. PubMed ID: 21310008
[TBL] [Abstract][Full Text] [Related]
6. Iron overload adversely affects outcome of allogeneic hematopoietic cell transplantation.
Pullarkat V; Blanchard S; Tegtmeier B; Dagis A; Patane K; Ito J; Forman SJ
Bone Marrow Transplant; 2008 Dec; 42(12):799-805. PubMed ID: 18762767
[TBL] [Abstract][Full Text] [Related]
7. Levels of non-transferrin-bound iron as an index of iron overload in patients with thalassaemia intermedia.
Taher A; Musallam KM; El Rassi F; Duca L; Inati A; Koussa S; Cappellini MD
Br J Haematol; 2009 Sep; 146(5):569-72. PubMed ID: 19604239
[TBL] [Abstract][Full Text] [Related]
8. Impact of pretransplant serum ferritin level on risk of invasive mold infection after allogeneic hematopoietic stem cell transplantation.
Dadwal SS; Tegtmeier B; Liu X; Frankel P; Ito J; Forman SJ; Pullarkat V
Eur J Haematol; 2015 Mar; 94(3):235-42. PubMed ID: 25082161
[TBL] [Abstract][Full Text] [Related]
9. Association between Plasma Endothelin-1, Transforming Growth Factor-β, Fibroblast Growth Factor, and Nitric Oxide Levels and Liver Injury in Hematopoietic Stem Cell Transplantation Recipients with Persistent Iron Overload after Transplantation.
Akı ŞZ; Suyanı E; Cengiz M; Özenirler S; Elbeğ Ş; Paşaoğlu H; Sucak GT
Biol Blood Marrow Transplant; 2015 May; 21(5):948-53. PubMed ID: 25681034
[TBL] [Abstract][Full Text] [Related]
10. Prognostic impact of posttransplantation iron overload after allogeneic stem cell transplantation.
Meyer SC; O'Meara A; Buser AS; Tichelli A; Passweg JR; Stern M
Biol Blood Marrow Transplant; 2013 Mar; 19(3):440-4. PubMed ID: 23089566
[TBL] [Abstract][Full Text] [Related]
11. Non-transferrin-bound iron during allogeneic stem cell transplantation.
Sahlstedt L; Ebeling F; von Bonsdorff L; Parkkinen J; Ruutu T
Br J Haematol; 2001 Jun; 113(3):836-8. PubMed ID: 11380478
[TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of iron parameters in patients undergoing allo-SCT.
Bazuaye GN; Buser A; Gerull S; Tichelli A; Stern M
Bone Marrow Transplant; 2012 Jan; 47(1):60-4. PubMed ID: 21399668
[TBL] [Abstract][Full Text] [Related]
13. Effective binding of free iron by a single intravenous dose of human apotransferrin in haematological stem cell transplant patients.
Sahlstedt L; von Bonsdorff L; Ebeling F; Ruutu T; Parkkinen J
Br J Haematol; 2002 Nov; 119(2):547-53. PubMed ID: 12406099
[TBL] [Abstract][Full Text] [Related]
14. Non-transferrin-bound serum iron (NTBI) in megaloblastic anemia: effect of vitamin B(12) treatment.
Gafter-Gvili A; Prokocimer M; Breuer W; Cabantchik IZ; Hershko C
Hematol J; 2004; 5(1):32-4. PubMed ID: 14745427
[TBL] [Abstract][Full Text] [Related]
15. Non-transferrin-bound iron and hepatic dysfunction in African dietary iron overload.
McNamara L; MacPhail AP; Mandishona E; Bloom P; Paterson AC; Rouault TA; Gordeuk VR
J Gastroenterol Hepatol; 1999 Feb; 14(2):126-32. PubMed ID: 10029292
[TBL] [Abstract][Full Text] [Related]
16. Serum non-transferrin-bound iron in beta-thalassaemia major patients treated with desferrioxamine and L1.
al-Refaie FN; Wickens DG; Wonke B; Kontoghiorghes GJ; Hoffbrand AV
Br J Haematol; 1992 Oct; 82(2):431-6. PubMed ID: 1419825
[TBL] [Abstract][Full Text] [Related]
17. Iron overload manifesting as apparent exacerbation of hepatic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Kamble RT; Selby GB; Mims M; Kharfan-Dabaja MA; Ozer H; George JN
Biol Blood Marrow Transplant; 2006 May; 12(5):506-10. PubMed ID: 16635785
[TBL] [Abstract][Full Text] [Related]
18. High nontransferrin bound iron levels and heart disease in thalassemia major.
Piga A; Longo F; Duca L; Roggero S; Vinciguerra T; Calabrese R; Hershko C; Cappellini MD
Am J Hematol; 2009 Jan; 84(1):29-33. PubMed ID: 19006228
[TBL] [Abstract][Full Text] [Related]
19. The Impact of Iron Overload in Acute Leukemia: Chronic Inflammation, But Not the Presence of Nontransferrin Bound Iron is a Determinant of Oxidative Stress.
Olcay L; Serteser M; Kolay M; Balci HF; Yildirim ÜM; Tekgündüz SA; Hazirolan T; Terzi YK
J Pediatr Hematol Oncol; 2017 Aug; 39(6):425-439. PubMed ID: 28731917
[TBL] [Abstract][Full Text] [Related]
20. Correlates of hepcidin and NTBI according to HFE status in patients referred to a liver centre.
Ryan E; Ryan JD; Russell J; Coughlan B; Tjalsma H; Swinkels DW; Stewart S; Crowe JP
Acta Haematol; 2015; 133(2):155-61. PubMed ID: 25277871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]